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General Experimental Methods. Reactions were conducted under N2 atmosphere in 
oven-dried glassware employing standard air-free manipulation techniques. 
 Reaction solvents were dried and distilled prior to use. Methylene chloride 
(CH2Cl2) was distilled from CaH2 under N2. All other reagents and solvents were used as 
received from commercial sources. Solvents were removed under reduced pressure using 
a rotary evaporator. 
 All chromatography was carried out with silica gel. Analytical TLC was carried 
out on silica gel plates. Reactions were routinely monitored by TLC. 
 
1H-NMR and 13C-NMR spectra were measured at 400 and 100 MHz, respectively. 
 
N-hydroxy-N-(methylacylfulvene)urea (8). To a solution of irofulven (200 mg, 
0.812 mmol) in a 1:1 mixture (8.0 mL) of acetone and 2M H2SO4 was added hydroxyurea 
(125 mg, 1.64 mmol). The mixture was stirred for 1 h at rt then partitioned between ethyl 
acetate and water. The organic extract was washed with saturated NaHCO3 and brine then 
dried with MgSO4 and concentrated. The crude product was chromatographed (1:3 
hexanes-ethyl acetate) to give 206 mg of 8 (83%) as an orange gum: 1H-NMR (CDCl3) δ 
0.70 (m, 1H), 1.07 (m, 1H), 1.36 (m, 1H), 1.36 (s, 3H), 1.48 (m, 1H), 2.08 (s, 3H), 2.17 
(s, 3H), 4.57 (d, J = 14.8 Hz, 1H), 4.80 (d, J = 14.8 Hz, 1H), 5.37 (br, 2H), 7.07 (s, 1H) 
13C-NMR (CDCl3) δ 10.0, 13.7, 14.7, 16.8, 27.9, 37.9, 46.0, 76.3, 126.4, 128.9, 135.1, 
138.5, 144.6, 160.8, 162.1, 198.2; HRMS for C16H21N2O4  (MH+) calcd 305.1501, found 
305.1505; UV λmax (EtOH) 332 nm (ε 6621). 
N-Acetoxy-N-(methylacylfulvene)urea (9). To a solution of 8 (20.4 mg, 67.0 
µmol) and Ac2O (7.0 µL, 74 µmol) in CH2Cl2 (2.0 mL) was added DMAP (2.0 mg, 16 
µmol). The mixture was stirred for 15 min then added directly to a silica gel column and 
chromatographed (10:1 hexanes-ethyl acetate) to give 23.2 mg of 9 (quant.) as an orange 
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gum: 1H-NMR (CDCl3) δ 1H-NMR (CDCl3) δ 0.71 (m, 1H), 1.06 (m, 1H), 1.35 (m, 1H), 
1.36 (s, 3H), 1.46 (m, 1H), 1.91 (s, 3H), 2.10 (s, 3H), 2.13 (s, 3H), 3.90 (br s, 1H), 4.77 
(br, 2H), 5.25 (s, 2H), 7.04 (s, 1H); 13C-NMR (CDCl3) δ 9.7, 13.2, 14.5, 17.0, 18.3, 27.6, 
38.0, 46.1, 76.4, 126.4, 127.1, 133.5, 138.5, 144.0, 159.5, 161.7, 167.6, 198.0; HRMS for 
C18H22N2O5 calcd 346.1529, found 346.1519; UV λmax (EtOH) 332 nm (ε 6673). 
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